The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis

G. D. Strizheva, T. Carsillo, W. D. Kruger, E. J. Sullivan, Jay H Ryu, E. P. Henske

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.

Original languageEnglish (US)
Pages (from-to)253-258
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume163
Issue number1
StatePublished - 2001
Externally publishedYes

Fingerprint

Lymphangioleiomyomatosis
Tuberous Sclerosis
Mutation
Exons
Genes
Germ-Line Mutation
Interstitial Lung Diseases
Smooth Muscle Myocytes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. / Strizheva, G. D.; Carsillo, T.; Kruger, W. D.; Sullivan, E. J.; Ryu, Jay H; Henske, E. P.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 163, No. 1, 2001, p. 253-258.

Research output: Contribution to journalArticle

Strizheva, G. D. ; Carsillo, T. ; Kruger, W. D. ; Sullivan, E. J. ; Ryu, Jay H ; Henske, E. P. / The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. In: American Journal of Respiratory and Critical Care Medicine. 2001 ; Vol. 163, No. 1. pp. 253-258.
@article{907ca6e1ec0e48a0a4555b2d500a1e13,
title = "The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis",
abstract = "Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.",
author = "Strizheva, {G. D.} and T. Carsillo and Kruger, {W. D.} and Sullivan, {E. J.} and Ryu, {Jay H} and Henske, {E. P.}",
year = "2001",
language = "English (US)",
volume = "163",
pages = "253--258",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis

AU - Strizheva, G. D.

AU - Carsillo, T.

AU - Kruger, W. D.

AU - Sullivan, E. J.

AU - Ryu, Jay H

AU - Henske, E. P.

PY - 2001

Y1 - 2001

N2 - Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.

AB - Lymphangiomyomatosis (LAM) is a progressive and often fatal interstitial lung disease characterized by a diffuse proliferation of abnormal smooth muscle cells in the lungs. LAM is of unusual interest biologically because it affects almost exclusively young women. LAM can occur as an isolated disorder (sporadic LAM) or in association with tuberous sclerosis complex (TSC). Because only a minority of women with TSC develops symptomatic LAM, we hypothesized that a relationship might exist between the type of germline TSC1 or TSC2 gene mutation and the risk of developing LAM. We examined all 41 exons of the TSC2 gene and 21 coding exons of the TSC1 gene for mutations in a group of 14 women with both TSC and LAM using single-strand conformation polymorphism analysis. Seven mutations were found in TSC2 and one in TSC1. Of the seven patients with TSC2 mutations, two had the same in-frame exon 40 deletion and one had an exon 41 missense change. We conclude that germline mutations in the extreme carboxy-terminus of tuberin can result in LAM. Further studies will be required to determine whether mutations in exons 40 and 41 are associated with an increased incidence and/or severity of LAM in women with TSC.

UR - http://www.scopus.com/inward/record.url?scp=0035155344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035155344&partnerID=8YFLogxK

M3 - Article

C2 - 11208653

AN - SCOPUS:0035155344

VL - 163

SP - 253

EP - 258

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -